Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 8/20 | 0.56 |
| ▸ | NPY1R | P25929 | 3/20 | 0.53 |
| ▸ | NPY2R | P49146 | 3/20 | 0.53 |
| ▸ | NPY4R | P50391 | 3/20 | 0.53 |
| ▸ | GHSR | Q92847 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 1/20 | 0.52 |
| ▸ | MMP14 | P50281 | 1/20 | 0.52 |
| ▸ | CCKAR | P32238 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12094757 | 0.94 | MC4R (0.58) | CCKBRKISS1R | |
| SCHEMBL30418415 | 0.94 | MC4R (0.58) | CCKBRKISS1R | |
| SCHEMBL12094755 | 0.94 | MC4R (0.58) | CCKBRKISS1R | |
| SCHEMBL12094801 | 0.94 | MC4R (0.58) | CCKBRKISS1R | |
| SCHEMBL12094764 | 0.94 | MC4R (0.58) | CCKBRKISS1R | |
| SCHEMBL12094797 | 0.94 | MC4R (0.58) | CCKBRKISS1R | |
| SCHEMBL18556749 | 0.94 | CCKBR (0.61) | CCKBRCCKAROPRD1KISS1R | |
| SCHEMBL18556702 | 0.94 | CCKBR (0.61) | CCKBRCCKAROPRD1KISS1R | |
| SCHEMBL18891478 | 0.90 | MC4R (0.59) | CCKBRCCKAROPRD1KISS1R | |
| SCHEMBL16677035 | 0.90 | MC4R (0.59) | CCKBRCCKAROPRD1KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES INC (US) | 2017-05-25 | — | — | US | disclosed |
| US-9580466-B2 | Melanocortin-1 receptor-specific linear peptides | PALATIN TECHNOLOGIES, INC. (US) | 2017-02-28 | — | — | US | disclosed |
| US-20150119341-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES INC (US) | 2015-04-30 | — | — | US | disclosed |
| US-8933194-B2 | Melanocortin-1 receptor-specific linear peptides | PALATIN TECHNOLOGIES, INC. (US) | 2015-01-13 | — | — | US | disclosed |
| US-20120225831-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES, INC. (US) | 2012-09-06 | — | — | US | disclosed |
| WO-2011063367-A1 | MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDES | PALATIN TECHNOLOGIES, INC. (US) | 2011-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | MC1R, MC5R, MC3R | CCKBR 71/4885NPY1R 5/4885NPY2R 7/4885 |
| US-20150119341-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | MC1R, MC3R, MC5R | CCKBR 81/4885NPY1R 7/4885NPY2R 12/4885 |
| US-20120225831-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | MC1R, MC3R, MC5R | CCKBR 81/4885NPY1R 7/4885NPY2R 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.